BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 37572195)

  • 1. Deep learning-based assessment of CT markers of sarcopenia and myosteatosis for outcome assessment in patients with advanced pancreatic cancer after high-intensity focused ultrasound treatment.
    Nowak S; Kloth C; Theis M; Marinova M; Attenberger UI; Sprinkart AM; Luetkens JA
    Eur Radiol; 2024 Jan; 34(1):279-286. PubMed ID: 37572195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of muscle mass using chest computed tomography-based quantitative and qualitative measurements in patients with systemic sclerosis: A retrospective study with cross-sectional and longitudinal analyses.
    da Rocha DS; Tessari JA; Mainardi NB; Hax V; Gasparin AA; de Oliveira CAV; Garcia TS; Xavier RM; Chakr RMDS
    Semin Arthritis Rheum; 2023 Apr; 59():152168. PubMed ID: 36736023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of deep learning-derived body composition in advanced pancreatic cancer-a retrospective multicenter study.
    Keyl J; Bucher A; Jungmann F; Hosch R; Ziller A; Armbruster R; Malkomes P; Reissig TM; Koitka S; Tzianopoulos I; Keyl P; Kostbade K; Albers D; Markus P; Treckmann J; Nassenstein K; Haubold J; Makowski M; Forsting M; Baba HA; Kasper S; Siveke JT; Nensa F; Schuler M; Kaissis G; Kleesiek J; Braren R
    ESMO Open; 2024 Jan; 9(1):102219. PubMed ID: 38194881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computed Tomographic Sarcopenia in Pancreatic Cancer: Further Utilization to Plan Patient Management.
    Jalal M; Campbell JA; Wadsley J; Hopper AD
    J Gastrointest Cancer; 2021 Sep; 52(3):1183-1187. PubMed ID: 34292498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy.
    Sahin TK; Ozbay Y; Altunbulak AY; Altunbulak HI; Onur MR; Ceylan F; Guven DC; Yalcin S; Dizdar O
    Int J Clin Oncol; 2024 Jun; 29(6):822-831. PubMed ID: 38565751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity is Associated with Longer Survival Independent of Sarcopenia and Myosteatosis in Metastatic and/or Castrate-Resistant Prostate Cancer.
    Xu MC; Huelster HL; Hatcher JB; Avulova S; Stocks BT; Glaser ZA; Moses KA; Silver HJ
    J Urol; 2021 Mar; 205(3):800-805. PubMed ID: 33080148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
    Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
    Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of Artificial Intelligence-Driven, Computed Tomography-Based, Volumetric Assessment of the Volume and Density of Muscle in Patients With Colon Cancer.
    Kim M; Lee SM; Son IT; Park T; Oh BY
    Korean J Radiol; 2023 Sep; 24(9):849-859. PubMed ID: 37634640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
    Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
    Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARC-F as a screening tool to detect computed tomography-based sarcopenia and myosteatosis among older adults with cancer.
    Hess DL; Harmon C; Bhatia S; Williams GR; Giri S
    Cancer Med; 2023 Nov; 12(22):20690-20698. PubMed ID: 37916460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
    Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
    BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of muscle measurement using the standardized phase of computed tomography in patients with advanced ovarian cancer.
    Huang CY; Sun FJ; Lee J
    Nutrition; 2020 Apr; 72():110642. PubMed ID: 31986319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the Overall Survival in Patients with Advanced Pancreatic Cancer by Calculating L3 Skeletal Muscle Index Derived from CT.
    Özkul B; Özkul Ö; Bilir C
    Curr Med Imaging; 2022; 18(10):1079-1085. PubMed ID: 35240961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal muscle is prognostic in resected stage III malignant melanoma.
    Youn S; Eurich DT; McCall M; Walker J; Smylie M; Sawyer MB
    Clin Nutr; 2022 May; 41(5):1066-1072. PubMed ID: 35397311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutritional status and skeletal muscle status in patients with head and neck cancer: Impact on outcomes.
    Findlay M; White K; Brown C; Bauer JD
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2187-2198. PubMed ID: 34676673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of muscle depletion on survival in peripheral arterial occlusive disease: Quality over quantity.
    Vedder IR; Levolger S; Dierckx RAJO; Zeebregts CJ; de Vries JPM; Viddeleer AR; Bokkers RPH
    J Vasc Surg; 2020 Dec; 72(6):2006-2016.e1. PubMed ID: 32330596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body composition measured by computed tomography is associated with colorectal cancer survival, also in early-stage disease.
    Shirdel M; Andersson F; Myte R; Axelsson J; Rutegård M; Blomqvist L; Riklund K; van Guelpen B; Palmqvist R; Gylling B
    Acta Oncol; 2020 Jul; 59(7):799-808. PubMed ID: 32228271
    [No Abstract]   [Full Text] [Related]  

  • 18. Fully Automated Deep Learning Tool for Sarcopenia Assessment on CT: L1 Versus L3 Vertebral Level Muscle Measurements for Opportunistic Prediction of Adverse Clinical Outcomes.
    Pickhardt PJ; Perez AA; Garrett JW; Graffy PM; Zea R; Summers RM
    AJR Am J Roentgenol; 2022 Jan; 218(1):124-131. PubMed ID: 34406056
    [No Abstract]   [Full Text] [Related]  

  • 19. Myosteatosis and aortic calcium score on abdominal CT as prognostic markers in non-dialysis chronic kidney disease patients.
    Kim A; Lee CM; Kang BK; Kim M; Choi JW
    Sci Rep; 2024 Apr; 14(1):7718. PubMed ID: 38565556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma.
    Kim DW; Ahn H; Kim KW; Lee SS; Kim HJ; Ko Y; Park T; Lee J
    Korean J Radiol; 2022 Nov; 23(11):1055-1066. PubMed ID: 36098341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.